Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of MR and APDT Vaccine

NCT01830257 is registered in ClinicalTrials.gov with Beijing Center for Disease Control and Prevention as lead sponsor.

NCT NCT01830257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01830257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of MR and APDT Vaccine
Lead sponsor
Beijing Center for Disease Control and Prevention
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2013
Completion date
June 30, 2014
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adverse reaction to drug